Organoids |
Robust; high throughput |
Difficult to control, many cardiac lineages, low perfusability; limited maturity and pharmaceutical responses; no organotypic behavior |
Screening for cardiotoxicity in early drug development phases |
Muscular thin films (MTFs) |
Organized structures, robust, high‐throughput; well‐developed and real‐time response measurement system |
Medium‐to‐low maturity; limited tissue organization; limited possibility for ECM development |
Screening of drug effects and cardiotoxicity |
Cell sheets |
Well established and standardized manufacturing procedures; unlimited tissue source; easy to handle in the laboratory |
Difficult for application for inexperienced medical staff; rely on proper homing and adhesion; limited complexity; use limited to the size of the tissue injury; relatively low throughput |
Regenerative medicine; heart infarction treatment |
Engineered heart tissue (EHT) |
Advanced maturation due to the mechanical stimulation in 3D environment; ECM allows for modeling of the larger than cellular scale disease effects; reproduces physiological features and complicated structural mechanisms of the heart tissue; response to the stimuli similar to mature human heart tissue; possibility to employ several cell types |
Complicated culture system; difficult to handle and measure (requires specific equipment); hard to standardize; low throughput |
Disease modeling; drug screening in preclinical phases; regenerative medicine (limited use) |
Heart‐on‐a‐chip |
Higher CM maturity; direct experimental access to the cell/tissue; controlled environment for cell development; medium–high throughput; automated cultures |
Complicated system requiring installation of the specific equipment and supply of additional gases and media; relatively low flexibility (requires changes in chip design, specific expertize, and equipment). High chip prices |
Drug screening for functionality and toxicity; studies of paracrine effect of the cells (combined media systems) |
De‐/Recellularized heart |
Mimic the properties of native heart matrix, maintain cell–cell contact and stiffness, mechanical anisotropy |
Difficult to reproduce, hard to recellularize in terms of cells compartmentalization; species/personal differences; require access to the source of human heart tissues in good shape—limits the accessibility of the technique (the only model to still have this limit); currently low physiological functionality; lowest throughput |
Heart transplantation procedures, replacement of the viable human heart organs |
In vivo mouse heart model |
Possibility to study hormonal regulation and organ‐to‐organ interactions in the whole organism |
Difference in physiology (ex. Action potential duration, heat rate), differences in ion channels expression (ex.) |
Basic research, preclinical studies (currently major model) |